Jushi & MariMed Talk Pennsylvania Strategy

https://is1-ssl.mzstatic.com/image/thumb/Podcasts116/v4/7d/f3/79/7df37980-2ed5-76e8-e593-fe558b47e92c/mza_9664767560994626786.jpg/600x600bb.jpg

The Dales Report | Trade to Black

Dales Media Group

413 episodes

6 hours ago

We are a business news platform that provides the latest and best insight into the stories that make headlines worldwide. From cannabis to psychedelics, crypto and more, we give institutional and retail investors an inside edge in the competitive world of investing. And we profile companies that are making waves in their ever-growing industries. We are The Dales Report. The information provided in this podcast is for educational purposes only and should not be considered as financial or investment advice. Listeners are encouraged to conduct their own research and co

Investing

Business

RSS

All content for The Dales Report | Trade to Black is the property of Dales Media Group and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Investing

Business

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/40370416/40370416-1706057696704-cfae7662e7e8e.jpg

Jushi & MariMed Talk Pennsylvania Strategy

The Dales Report | Trade to Black

44 minutes 17 seconds

1 week ago

Jushi & MariMed Talk Pennsylvania Strategy

Pennsylvania could be the next big story in U.S. cannabis — and this time, it feels like something real is happening. With more than 440,000 medical patients, $1.7 billion in yearly sales, and a new Senate bill to create a Cannabis Control Board, the Keystone State looks like it’s quietly getting ready for adult-use legalization. But how close are we, really?On this episode of TDR Trade To Black, host Shadd Dales sits down with Trent Woloveck, Chief Strategy Officer at Jushi Holdings (OTCQX: JUSHF), and Ryan Crandall, Chief Commercial Officer at MariMed (CSE: MRMD), to talk through what’s actually going on behind the scenes. They cover Pennsylvania’s reform timeline, the fight over hemp-derived THC, and how both companies are positioning themselves for when the market finally opens up.From Jushi’s massive vertical footprint — with 18 dispensaries and a 160,000 sq ft grow — to MariMed’s brand-driven playbook built around Standard Farms, this panel gets into what legalization could mean for retail, consumers, and investors if rescheduling lands in 2025.Could Pennsylvania be the state that finally shifts national momentum? Let’s find out.#TradeToBlack #CannabisInvesting #PennsylvaniaCannabis #JushiHoldings #MariMed #CannabisReform #CannabisStocks #AdultUseCannabis #CannabisPolicy #ShaddDalesWant to see last week's recap? • Pennsylvania Sets Stage for Adult-Use | TT... Want to see more Cannabis Reform videos? • Could Massachusetts Reverse Legal Cannabis... • Big Change Is Coming to Cannabis Over the ... • Pennsylvania Takes Major Cannabis Step | T... • FLA State Officials Throw Out 200K Signatu... Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook: / thedalesreport Twitter: / thedalesreport Instagram: / dalesreport LinkedIn: / the-dales-report Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, please get in touch with us at:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered as endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions you make based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...